IP Verse

Oral Solid Preparation Comprising Aripiprazole And Method For Producing Oral Solid Preparation Comprising Aripiprazole

Patent No. EP2838513 (titled "Oral Solid Preparation Comprising Aripiprazole And Method For Producing Oral Solid Preparation Comprising Aripiprazole") was filed by Otsuka Pharmaceutical on Apr 18, 2014. The application was issued on Apr 5, 2017.

Patent Summary

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
TEVA PHARMACEUTICALS	Jan 5, 2018	KOCHER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Feb 12, 2026
Brief communication - Opposition proceedings
Feb 4, 2026
Withdrawal of an opposition
Oct 8, 2021
Letter accompanying subsequently filed items
Oct 8, 2021
Request for a change of address - opponent
May 17, 2018
Communication to the parties concerning the termination of opposition procedure - opposition deemed not filed (opponent)
May 17, 2018
Communication to the parties concerning the termination of the opposition proceedings - opposition deemed not filed (proprietor)
May 14, 2018
Termination of the opposition proceedings with maintenance of patent
Feb 13, 2018
Brief communication - Opposition proceedings
Feb 13, 2018
Noting of loss of rights (opposition deemed not to have been filed)
Feb 5, 2018
(Electronic) Receipt
Feb 5, 2018
Letter accompanying subsequently filed items
Feb 5, 2018
Letter regarding the opposition procedure (no time limit)
Jan 31, 2018
Communication of a notice of opposition - first information to patent proprietor
Jan 23, 2018
Important information concerning EPO Form 1010
Jan 5, 2018
Non-patent literature cited during the opposition procedure
Jan 5, 2018
Non-patent literature cited during the opposition procedure
Jan 5, 2018
Non-patent literature cited during the opposition procedure
Jan 5, 2018
Non-patent literature cited during the opposition procedure
Jan 5, 2018
Non-patent literature cited during the opposition procedure
Jan 5, 2018
Notice of opposition
Jan 5, 2018
Notice of opposition
Jan 5, 2018
Patent document cited during the opposition procedure
Jan 5, 2018
Patent document cited during the opposition procedure
Jan 5, 2018
Patent document cited during the opposition procedure
Jan 5, 2018
Payment of fees and costs
Jan 5, 2018
Payment of fees and costs
Apr 6, 2017
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Mar 9, 2017
Decision to grant a European patent
Mar 6, 2017
Decision to allow further processing
Feb 20, 2017
French translation of claims
Feb 20, 2017
German translation of the claims
Feb 20, 2017
Payment of fees and costs
Feb 20, 2017
Request for further processing
Dec 20, 2016
Application deemed to be withdrawn ( translations of claims/payment missing)
Aug 22, 2016
Processing of request for correction of text proposed for grant or third party observations (from 01-04-2012)
Aug 9, 2016
Transmittal of third party observations to applicant
Aug 4, 2016
Processing of request for correction of text proposed for grant or third party observations (from 01-04-2012)
Jul 25, 2016
Citation filed by a third party
Jul 25, 2016
Observations by third parties
Jun 29, 2016
Bibliographic data of the European patent application
Jun 29, 2016
Communication about intention to grant a European patent
Jun 29, 2016
Intention to grant (signatures)
Jun 29, 2016
Text intended for grant (clean copy)
Jun 29, 2016
Text intended for grant (version for approval)
Mar 16, 2016
Claims
Mar 16, 2016
Description
Mar 16, 2016
Reply to communication from the Examining Division
Dec 4, 2015
Communication to designated inventor
Dec 4, 2015
Communication to designated inventor
Dec 4, 2015
Communication to designated inventor
Nov 16, 2015
Copy of the international preliminary report on patentability
Nov 6, 2015
Annex to the communication
Nov 6, 2015
Communication from the Examining Division
Sep 3, 2015
Claims
Sep 3, 2015
Description
Sep 3, 2015
Reply to communication from the Examining Division
Apr 23, 2015
Annex to the communication
Apr 23, 2015
Communication from the Examining Division
Apr 16, 2015
Examination started
Jan 28, 2015
Notification on forthcoming publication of bibliographic data
Jan 21, 2015
Matter concerning the application
Jan 8, 2015
(Electronic) Receipt
Jan 8, 2015
Letter concerning fees and payments
Dec 5, 2014
Communication regarding comments on written opinion/amendment of application/payment of claims fee
Nov 25, 2014
Priority document (electronically transmitted)
Nov 25, 2014
Priority document (electronically transmitted)
Nov 19, 2014
(Electronic) Receipt
Nov 19, 2014
Amended claims filed after receipt of (European) search report
Nov 19, 2014
Amendments received before examination
Nov 19, 2014
Request for entry into the European phase
Nov 6, 2014
Copy of the international search report
Nov 6, 2014
Priority document
Nov 6, 2014
Priority document
Nov 6, 2014
Published international application - A1
Sep 11, 2014
Written opinion of the ISA, boxes No. I to VIII
Sep 11, 2014
Written opinion of the ISA, cover sheet
Sep 11, 2014
Written opinion of the ISA, supplemental box
Jun 10, 2014
Abstract
Jun 10, 2014
Claims
Jun 10, 2014
Description
Jun 10, 2014
Drawings

EP2838513

OTSUKA PHARMACEUTICAL

Application Number: EP14729061A
Filing Date: Apr 18, 2014
Status: Granted And Under Opposition; Mar 3, 2017
Publication Date: Apr 5, 2017
External Links: Slate, Register , Google Patents